Growing Awareness And Diagnosis Drive Avian Flu Treatment Market Growth: Core Growth Enabler in the Avian Flu Treatment Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Avian Flu Treatment Industry Market Size Be by 2025?
The market size of treatments for bird flu has shown robust growth in the past years, and is projected to expand from $12.59 billion in 2024 to $13.81 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this significant growth in the past include heightened demand for avian flu treatments, enhanced efforts to limit the transmission of bird flu, an increase in available therapeutic options, more investment in health care facilities and infrastructure, as well as a greater demand for poultry consumption.

What's the Long-Term Growth Forecast for the Avian Flu Treatment Market Size Through 2029?
The market for avian flu treatment is predicted to experience significant expansion in the up-coming years, culminating at $19.69 billion in the year 2029, with a compound annual growth rate (CAGR) of 9.3%. This anticipated growth within the projected period can be attributed to factors such as increased awareness and diagnosis, government strategies for handling pandemics, escalating investments in research and development, the urgency for effective therapeutics to combat avian flu, and extensive efforts made in research and development. Other upcoming trends in the forecast period encompass the development of unique therapeutic procedures, futuristic innovations and technologies, cooperative research endeavours, new business ventures and investment opportunities, as well as advances in telemedicine and remote consultation services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Avian Flu Treatment Market Expansion?
The anticipated growth of the avian flu treatment market is largely tied to increased awareness and diagnosis. Awareness refers to the understanding of a condition, while diagnosis is the precise identification of the issue based on that understanding. The necessity for avian flu treatment emerges from the urgent need to ensure public health, thwart possible pandemics, and shield poultry populations from significant economic losses. Recognition and early diagnosis play a vital role in the effective treatment of avian flu, allowing immediate intervention and containment to halt further spread. For example, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported in April 2024 that over 8000 individuals had been under active monitoring in the US from February 9, 2022, to March 29, 2024, following exposure to animals suspected to be infected with the HPAI A (H5N1) virus. Hence, the increase in awareness and diagnosis is fuelling the growth of the avian flu treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp

What Are the Key Trends Driving Avian Flu Treatment Market Growth?
To increase efficiency and quicken the process of new treatment development, major firms in the avian flu treatment market are opting for partnerships. These partnerships include unionization of pharmaceutical corporations, research bodies, and government units to provide shared resources, pooled knowledge, and provide innovative clinical trial opportunities. For instance, GSK plc - a UK-based pharmaceutical corporation - entered into a partnership with CureVac N.V., a biotechnology firm based in Germany, in April 2024. The partnership is aimed at creating an experimental Influenza A (H5N1) pre-pandemic vaccine to combat the future potential pandemic threat that could be caused by the H5N1 avian influenza virus. Their goal is to assess the safety, reactogenicity, and immunogenicity of their monovalent vaccine, which makes use of an influenza A H5-antigen created using CureVac's unique second-generation mRNA backbone. The integrated Phase 1/2 study will analyze the safety and effectiveness of this vaccine candidate in healthy adults ranging in age from 18 to 64 years, and also in older adults who are between 65 and 85 years old.

How Is the Avian Flu Treatment Market Segmented?
The avian flu treatment market covered in this report is segmented -

1) By Type: Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
2) By Distribution Channel: Online Pharmacies, Offline Pharmacies
3) By End User: Hospital, Institutional Health Centers, Clinics

Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Tetracycline Antibiotics, Penicillin-Based Antibiotics, Macrolide Antibiotics, Cephalosporins, Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), M2 Ion Channel Inhibitors (Amantadine), Polymerase Inhibitors, Protease Inhibitors, Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp

Which Companies Are Leading the Charge in Avian Flu Treatment Market Innovation?
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma

Which Regions Are Leading the Global Avian Flu Treatment Market in Revenue?
North America was the largest region in the avian flu treatment market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16352

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.